A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300
复制标题
一项随机对照试验，评估间歇性 3 天、4 天和 5 天周期静脉注射重组人白细胞介素 2 联合抗逆转录病毒治疗 (ART) 与单独 ART 在 100-300 名 HIV 血清阳性患者中的疗效和安全性
DOI：
10.1016/s1521-6616(02)00038-4
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
Mitsuyasu,RonaldT
中科院分区：
文献类型：
--
作者：
deBoer,AlberdinaW;Markowitz,Norman;Lane,HClifford;Saravolatz,LouisD;Koletar,SusanL;Donabedian,Haig;Yoshizawa,Carl;Duliege,Anne-Marie;Fyfe,Gwendolyn;Mitsuyasu,RonaldT
